MEET THE PEN
PEN FEATURES THAT GUIDE EACH STEP
The KESIMPTA® auto-injector pen is designed to help you use it safely, right from the comfort of home, once a month.* Someone from your health care team will show you how to use it first so you'll be ready on treatment day.
†KESIMPTA pens come with a staked needle of 29-gauge. Pediatric needles average between 23-gauge and 25-gauge.
Artist, MS Advocate, and Real Patient
Switched to KESIMPTA: 2022
“The way the pen is designed puts the needs of people like me first.”
THE PEN IS EASY TO USE‡
In a real-world survey,‡ people described their experience with the auto-injector pen. Here's what they had to say:
§Based on a survey of MS nurses (N=50) and patients (N=80) in the US, Germany, France, and Italy. Participants were asked to compare attributes of the KESIMPTA auto-injector pen with those of other disease modifying therapy (DMT) auto-injectors, some of which are not available in the US. The KESIMPTA pen was not injected during the survey, nor were all devices compared against each other by participants. A total of 17 attributes were assessed, with “easy to perform self-injection with the pen,” “ease of preparation and set-up,” and “ease of training patient in use” among those most preferred.
GET STARTED WITH CONFIDENCE
Before starting KESIMPTA, someone from your health care team will show you how to take it. But if you’d like extra support to feel ready, more training resources are available here—and you can even get help with your first dose at your doctor’s office.
If you want, a training pen is available to help you practice before using the actual auto-injector pen.
The pen comes prefilled and ready to go when you are||—no premedications¶ like steroids or 1st dose observation required.
¶Only limited benefit of premedication with corticosteroids, antihistamines, or acetaminophen was seen in RMS clinical studies.
Up Next:
Discover how KESIMPTA can fit into your life.
Want more info to help you decide?
Find out why so many people are choosing KESIMPTA.
Prescribed KESIMPTA?
96% of all prescriptions filled paid as little as $0 out of pocket cost when used with the Co-Pay Plus offer.#**
RMS, relapsing multiple sclerosis.
#Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit up to $18,000. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice. See complete Terms & Conditions at start.kesimpta.com.
**2025 data on file.